Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Federal Judges Issue Opposing Rulings on Mifepristone

Late Friday evening, two federal judges in different states issued contradictory decisions that could impact access to mifepristone, a drug used in nearly all medication abortions in the United States. In a Texas case, the Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al court case, the judge stayed the U.S. Food and Drug Administration’s (FDA) approval of mifepristone. This will not go into effect until April 14th at the earliest. 

Less than an hour later, we saw a federal district court judge in Washington State issue a preliminary injunction in a case brought by 18 Democratic Attorneys General (Washington, Oregon, Arizona, Colorado, Connecticut, Delaware, Illinois, Michigan, Nevada, New Mexico, Rhode Island, Vermont, Maryland, Minnesota, Pennsylvania, Maine, D.C., Hawaii) to safeguard access to mifepristone. The ruling prevents the FDA from altering the status quo with respect to the availability of mifepristone in the 18 plaintiff states. 

Much remains unclear about the combined effects of these two rulings. Here’s what we do know: the use of mifepristone remains legal at this point in time, and medication abortion will remain available at PPCWNY regardless of the final outcome of these cases. 

Mifepristone is one of two medications most commonly used in medication abortion in the United States and was approved for use by the FDA more than 20 years ago. Although it has been presented as a safety issue, the Alliance case has always been a politically motivated attack on reproductive rights. We know that the goal of extreme anti-abortion actors is to ban abortion, birth control, and other sexual and reproductive healthcare nationwide. Simply put, they want to fully control what people do with their bodies.

The truth is that medication abortion is incredibly safe and effective. It expands abortion access, reduces abortion stigma, and empowers patients to make their own private medical decisions. Mifepristone has been used by more than five million people in the United States since 2000 to safely end their pregnancies. 

At Planned Parenthood of Central and Western New York, we will continue to provide essential health care – including medication abortion. Everyone deserves the right to decide what is best for their body, their health, and their future. We are committed to ensuring access to medication abortion with as few barriers as possible. Patients who have questions about what this may mean for their particular circumstances are encouraged to contact our health centers.


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.